Neuspera Medical Raises $23 Million for FDA Approval and Growth

Neuspera Medical Raises $23M in Series D Funding

Neuspera Medical (Linkedin), a leader in neuromodulation technology, recently secured $23M in Series D funding to advance their implantable medical device system for patients battling urinary urge incontinence caused by overactive bladder. With FDA premarket approval on the horizon, Neuspera Medical is poised to make a significant impact in the medical equipment manufacturing industry.

Funding Amount: $23 million

Industry: Medical Equipment Manufacturing

Employee Count: 11-50

CEO: Steffen Hovard (CEO Linkedin)

What Neuspera Medical needs to buy: Neuspera Medical is seeking partnerships with regulatory and compliance service providers, manufacturers for their implantable medical devices, and marketing and sales experts to effectively reach their target market of healthcare providers and distributors. Companies specializing in medical device regulations, manufacturing, and distribution are ideal partners for Neuspera Medical's growth and success.